홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
MGNX
#3585
MacroGenics, Inc.
3.4
9
USD
+0.58%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+0.58%
월간 변동
+15.18%
6달 변화
+115.43%
년간 변동율
+166.41%
이전 종가
3.4
7
Open
3.4
9
Bid
Ask
Low
3.4
9
High
3.4
9
양
80
마켓
주식
헬스케어
MGNX
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
56.26 M
61.32 M
61.84 M
62.43 M
63.09 M
63.56 M
—
Valuation ratios
Enterprise value
1.1 B
860.79 M
284.41 M
534.6 M
22.2 M
45.11 M
-48.4 M
Price to earnings ratio
—
-4.76
-3.26
-67.87
-3.04
-1.36
-6.38
Price to sales ratio
—
12.42
2.57
10.73
1.36
0.68
2.49
Price to cash flow ratio
—
-6.69
-4.49
-8.06
-2.98
-1.25
-4.11
Price to book ratio
—
4.02
2.75
4.13
1.75
1.83
2.6
EBITDA 비율에 대한 기업 가치
-9.28
-4.49
-2.6
-3.37
-0.22
-0.69
0.55
Profitability ratios
Return on assets %
-0.34
-0.6
-0.43
-0.03
-0.26
-0.29
-0.32
Return on equity %
-0.44
-0.84
-0.84
-0.06
-0.58
-1.34
-1.3
Return on invested capital %
-338.26
-510.33
-323.56
-442.07
-386.54
-242.7
-426.39
Gross margin %
100
96.58
97.79
98.95
99.44
100
400
Operating margin %
-124.96
-261.85
-79.91
-286.38
-73.74
-48.72
-492.13
EBITDA margin %
-113.56
-247.31
-72.1
-269.96
-68.71
-43.93
-463.54
Net margin %
-123.7
-260.97
-78.82
-15.42
-44.66
-49.91
-485.3
Liquidity ratios
Quick ratio
—
3.69
4.54
4.46
3.92
4.92
18.07
Current ratio
6.17
3.75
4.57
4.48
3.92
5.1
18.86
Inventory turnover
—
0.6
1.15
0.46
1.39
0
0
Asset turnover
0.3
0.22
0.49
0.2
0.54
0.58
0.59
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-2.4
-1.42
-1.26
-1.09
-1.28
-1.28
EBIT per share
—
-3.38
-1.98
-2.72
-1.77
-1.15
-1.16
EBITDA per share
—
-3.2
-1.78
-2.56
-1.65
-1.04
-1.04
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
2.06
1.77
1.63
2.92
0.91
6.55
Net current asset value per share
—
4.66
3.62
4.06
3.47
3.48
13.29
Tangible book value per share
—
4
2.31
2.46
1.85
0.88
3.93
Working capital per share
—
3.42
2.83
3.15
2.59
2.8
10.4
Book value per share
—
4
2.31
2.46
1.85
0.88
3.93
뉴스
MacroGenics: Oncology Opportunities In Play, But Investing Feels Like A Gamble (MGNX)
MacroGenics, 2026년 전략적 재도약 목표 제시
MacroGenics at The Citizens Life Sciences Conference: Strategic Reemergence in 2026
매크로제닉스, Leerink 헬스케어 컨퍼런스 참가
MacroGenics at Leerink Global Healthcare Conference: Strategic Pipeline Focus
스티펠, MacroGenics에 ’보유’ 등급 유지, 목표가 4달러
Stifel reiterates MacroGenics stock rating with $4 price target
MacroGenics Inc Q1 실적 에상치보다 저조, 수익 예상치를 넘어
MacroGenics Inc earnings missed by $0.03, revenue topped estimates
MacroGenics (MGNX) Reports Q4 Loss, Tops Revenue Estimates
Stifel reiterates Incyte stock rating after FDA setback
매크로제닉스, TD Cowen 컨퍼런스서 전략적 필수 과제 강조